    <SEC-DOCUMENT>0001140361-26-023583-index.html : 20260601
    <SEC-HEADER>0001140361-26-023583.hdr.sgml : 20260601
    <ACCEPTANCE-DATETIME>20260601170021
    ACCESSION NUMBER:		0001140361-26-023583
    CONFORMED SUBMISSION TYPE:	DEF 14A
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20260716
    FILED AS OF DATE:		20260601
    DATE AS OF CHANGE:		20260601

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001649989
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				383982704
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			0930

    	FILING VALUES:
    		FORM TYPE:		DEF 14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37759
    		FILM NUMBER:		261052098

    	BUSINESS ADDRESS:
    		STREET 1:		111 S. WOOD AVENUE
    		STREET 2:		UNIT #100
    		CITY:			ISELIN
    		STATE:			NJ
    		ZIP:			08830
    		BUSINESS PHONE:		6096193990

    	MAIL ADDRESS:
    		STREET 1:		111 S. WOOD AVENUE
    		STREET 2:		UNIT #100
    		CITY:			ISELIN
    		STATE:			NJ
    		ZIP:			08830

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Oncobiologics, Inc.
    		DATE OF NAME CHANGE:	20150804
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEF 14A
    <SEQUENCE>1
    <FILENAME>ny20071594x2_def14a.htm
    <DESCRIPTION>DEF 14A
    <TEXT>
    Document 1 - file: ny20071594x2_def14a.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>logo_outlookthera.jpg
    <TEXT>
    Document 2 - file: logo_outlookthera.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>ny20071594x2_pc01.jpg
    <TEXT>
    Document 3 - file: ny20071594x2_pc01.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>ny20071594x2_pc02.jpg
    <TEXT>
    Document 4 - file: ny20071594x2_pc02.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>